Table 2.
Biochemical data of study participants at baseline.
| Variables | RYGB (n = 16) | VLCD (n = 15) | p-Value |
|---|---|---|---|
| FPG, mg/dL | |||
| All patients | 123.7 ± 45.0 | 123.5 ± 59.0 | 0.994 |
| Patients with T2D | 142.3 ± 75.2 | 180.2 ± 75.2 | 0.362 |
| Patients without T2D | 109.2 ± 18.7 | 95.2 ± 14.9 | 0.086 |
| HbA1c, % | |||
| All patients | 6.9 ± 1.8 | 7.0 ± 2.5 | 0.894 |
| Patients with T2D | 8.1 ± 2.3 | 9.5 ± 3.1 | 0.367 |
| Patients without T2D | 5.9 ± 0.4 | 5.7 ± 0.4 | 0.205 |
| Total cholesterol, mg/dL | 178.3 ± 33.1 | 216.8 ± 38.9 | 0.006 |
| Triglyceride, mg/dL | 144.2 ± 66.2 | 133.5 ± 68.7 | 0.661 |
| HDL cholesterol, mg/dL | 46.4 ± 7.8 | 46.7 ± 10.5 | 0.930 |
| LDL cholesterol, mg/dL | 131.9 ± 38.4 | 158.6 ± 38.5 | 0.063 |
| Uric acid, mg/dL | 6.5 ± 1.9 | 7.2 ± 1.8 | 0.257 |
| Serum creatinine, mg/dL | 0.7 ± 0.3 | 0.7 ± 0.1 | 0.476 |
| eGFR, mL/min/1.73 m2 | 107.7 ± 25.4 | 118.7 ± 14.3 | 0.148 |
| AST, U/L | 33.8 ± 19.9 | 50.9 ± 62.0 | 0.319 |
| ALT, U/L | 36.9 ± 23.3 | 77.9 ± 113.5 | 0.182 |
Data are presented as mean ± standard deviation. RYGB, Roux-en-Y gastric bypass; VLCD, very low-calorie diet; T2D, type 2 diabetes; FPG, fasting plasma glucose; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; eGFR, estimated glomerular filtration rate; AST, aspartate aminotransferase; ALT, alanine transaminase.